Your browser doesn't support javascript.
loading
Catalyzing a Cure: Discovery and development of LRRK2 inhibitors for the treatment of Parkinson's disease.
Baidya, Anurag Tk; Deshwal, Sonam; Das, Bhanuranjan; Mathew, Alen T; Devi, Bharti; Sandhir, Rajat; Kumar, Rajnish.
Afiliación
  • Baidya AT; Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U.), Varanasi 221005, UP, India.
  • Deshwal S; Department of Biochemistry, Panjab University, Chandigarh 160014, India.
  • Das B; Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U.), Varanasi 221005, UP, India.
  • Mathew AT; Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U.), Varanasi 221005, UP, India.
  • Devi B; Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U.), Varanasi 221005, UP, India.
  • Sandhir R; Department of Biochemistry, Panjab University, Chandigarh 160014, India.
  • Kumar R; Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U.), Varanasi 221005, UP, India. Electronic address: rajnish.phe@iitbhu.ac.in.
Bioorg Chem ; 143: 106972, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37995640

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Idioma: En Revista: Bioorg Chem Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Idioma: En Revista: Bioorg Chem Año: 2024 Tipo del documento: Article